reboxetine has been researched along with kynurenic acid in 1 studies
| Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (kynurenic acid) | Trials (kynurenic acid) | Recent Studies (post-2010) (kynurenic acid) |
|---|---|---|---|---|---|
| 626 | 193 | 184 | 2,611 | 28 | 750 |
| Protein | Taxonomy | reboxetine (IC50) | kynurenic acid (IC50) |
|---|---|---|---|
| Neuronal acetylcholine receptor subunit alpha-7 | Homo sapiens (human) | 7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harkin, A; Kelly, JP; Leonard, BE; Nally, R | 1 |
1 other study(ies) available for reboxetine and kynurenic acid
| Article | Year |
|---|---|
Effects of reboxetine and sertraline treatments alone and in combination on the binding properties of cortical NMDA and beta1-adrenergic receptors in an animal model of depression.
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Animals; Cerebral Cortex; Depressive Disorder; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Kynurenic Acid; Male; Morpholines; Neurons; Norepinephrine; Propanolamines; Rats; Rats, Sprague-Dawley; Reboxetine; Receptors, Adrenergic, beta-1; Receptors, N-Methyl-D-Aspartate; Serotonin; Sertraline | 2000 |